Fpc Investment Advisory »

Summit Therapeutics shares owned by Fpc Investment Advisory

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Fpc Investment Advisory from 13F filings

Historical chart of Fpc Investment Advisory investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Fpc Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Fpc Investment Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.0k 1.9k 3.59

More positions owned by Fpc Investment Advisory

Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Blackrock Ultra (ICSH)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Europe Etf (IEV)
Vanguard World Inf Tech Etf (VGT)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Invesco Exchange Traded Fd T S&p500 Eql Enr (RSPG)
Ishares Tr Msci Ac Asia Etf (AAXJ)
Ishares Msci Jpn Etf New (EWJ)
Vanguard Bd Index Fds Long Term Bond (BLV)

View all positions for Fpc Investment Advisory

Top funds holding Summit Therapeutics

BlackRock
State Street Corporation
FMR
Vanguard Group
Geode Capital Management
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Goldman Sachs Group
Rafferty Asset Management
Steward Partners Investment Advisory
Bank Of Montreal
Citigroup
Federated Investors
ALPS Advisors

View all funds holding Summit Therapeutics